Announces Its Morning Stock Focus List for Thursday, July 11, 2002: LAMP, LGND, ZRAN, INAP and SMTC

Weston, Florida, UNITED STATES

WESTON, Fla., July 11, 2002 (PRIMEZONE) --'s morning report announces the following stock picks for the short-term investor: (More is available at

Keep an eye on LAM Pharmaceutical, Corp. (OTCBB:LAMP). LAMP just release huge news and could be a huge gainer in the short term.

Ligand Pharmaceuticals (Nasdaq:LGND): Market UNDERPERFORM, down 32% on 4 million shares after updating AVINZA Launch progress.

Zoran Corporation (Nasdaq:ZRAN): Short-term ATTRACTIVE, down 22% on 4 million shares after announcing new Integrated DVD System-On-A-Chip Solution.

InterNAP Network Services (Nasdaq:INAP): Market OUTPERFORM, up 19% on 1.8 million shares after Q2 Earnings Release information.

Semtech Corporation (Nasdaq:SMTC), Market OUTPERFORM, down 12% on 1.8 million shares after recent buyback announcement.

About, a leader in corporate communications and finance, provides all investors with a wide-ranging set of financial tools, including original stock market commentary, stock quotes, interactive charts, portfolio watch, live chat and message boards, etc., plus the latest news, press releases, investment opinions, and research reports for all companies highlighted on the site. For more daily commentary, go to

Copyright 2002, All rights reserved.

All material herein was prepared by Capital Research Group, Inc. (CRG) based upon information believed to be reliable. The information contained herein is not guaranteed by CRG to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. CRG has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion. (three hundred seventy five thousand lamp. CRG will receive six hundred thousand shares of lamp if contract is completed) CRG intends to sell its shares. CRG has sold approximately three hundred thousand lamp shares to date. CRG may sell its shares for less than the target price given in this opinion. CRG's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Peter Antipatis, CRD number 2955420. CRG will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.


Contact Data